Workshop D – Looking into the Future: Redosing Gene Therapies
Time: 1:00 pm
day: Clinical Track - PM
Details:
- Examining the differences in redosing for local gene therapies and systemic gene therapies
- Understanding the regulatory bodies’ perspective on redosing Nab-positive patients
- Examining the challenges of redosing at high doses
- Discussing the risk-benefit ratio for patients for redosing
- Uncovering immunodepleting strategies to effectively enable redosing
